BrainStorm Cell Therapeutics
BCLI
#10185
Rank
A$10.84 M
Marketcap
$1.90
Share price
-6.50%
Change (1 day)
-87.16%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.89

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.98. In 2022 the company made an earnings per share (EPS) of -$1.09 an increase over its 2021 EPS that were of -$1.12.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-18.69%
2022-$1.09-2.94%
2021-$1.12-37.04%
2020-$1.791.89%
2019-$1.7551.43%
2018-$1.16159.26%
2017-$0.45-3.57%
2016-$0.46-37.78%
2015-$0.74-33.82%
2014-$1.1236%
2013-$0.8311.11%
2012-$0.7450%
2011-$0.50-50%
2010-$0.99-233.33%
2009$0.74-142.86%
2008-$1.74-65%
2007-$4.96
2005$1.64-108.03%
2004-$20.4013203.07%
2003-$0.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.26-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.41 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.63 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.53-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.41 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA